Corrado Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Corrado Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-180	Closed	-$14.9K	–	387
2022 Q4	$14.9K	Buy	+180	New	+$14.6K	0.01%	208
2020 Q2	–	Sell	-7,140	Closed	-$552K	–	84
2020 Q1	$552K	Buy	7,140 +1,852	+35%	+$164K	0.52%	38
2019 Q4	$503K	Buy	5,288 +185	+4%	+$16K	0.45%	40
2019 Q3	$389K	Buy	5,103 +235	+5%	+$19.5K	0.35%	50
2019 Q2	$427K	Buy	4,868 +297	+6%	+$25.3K	0.38%	46
2019 Q1	$414K	Buy	4,571 +55	+1%	+$4.68K	0.38%	46
2018 Q4	$324K	Buy	4,516 +20	+0.4%	+$1.61K	0.32%	55
2018 Q3	$431K	Buy	4,496 +308	+7%	+$29.9K	0.28%	58
2018 Q2	$398K	Buy	4,188 +365	+10%	+$33.5K	0.24%	68
2018 Q1	$335K	Buy	+3,823	New	+$349K	0.2%	78

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Corrado Advisors's XBI Position: Q1 2023 in Review

Corrado Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2023, closing a stake of 180 shares — an estimated $14.9K sold.

Corrado Advisors first reported a position in XBI in Q1 2018 and held it in 10 quarters. The position peaked at $552K in Q1 2020. 712 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

Corrado Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2023 after selling out during the quarter.
Corrado Advisors sold 180 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $14.9K.
Corrado Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and held it in 10 quarters.
Corrado Advisors's State Street SPDR S&P Biotech ETF position peaked at $552K in Q1 2020.
712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on Corrado Advisors's 13F filing for Q1 2023, filed 3 May 2023.